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Introduction
It is now clear after more than two decades of space exploration that one of the major short- and
long-term effects of microgravity on the human body is the loss of bone. The purpose of this
presentation will be to review the data regarding the impact of microgravity and bed rest on calcium
and bone metabolism. I will take the position in this Socratic debate that the effect of microgravity
on bone metabolism can either be reversed or be mitigated.
As we begin to contemplate long-duration space flight, habitation of Space Station Freedom and
the Moon, one of the issues that will need to be addressed is whether humans need to maintain a
skeleton that has been adapted for the one-g force on Earth? Clearly in the foreseeable future a
healthy and structurally sound skeleton will be required for astronauts to shuttle back and forth
from Earth to the Moon, Space Station, and Mars. Based on most available data from bed-rest
studies and the short- and long-duration microgravity experiences by astronauts and cosmonauts,
bone loss is a fact of life in this environment. With the rapid advances in our understanding of
bone physiology is it now possible to contemplate measures that can prevent or mitigate
microgravity-induced bone loss. Will the new therapeutic approaches for enhancing bone
mineralization be useful for preventing significant bone loss during long-term space flight? Are
there other approaches such as exercise and electrical stimulation that can be used to mitigate the
impact of microgravity on the skeleton? A recent study that evaluated the effect of microgravity on
bone modeling in developing chick embryos may perhaps provide a new perspective about the
= _pact of microgravity on bone metabolism.
Human Bone Disease: Historical Perspective and Concerns for the Future
Bone disease has afflicted humans almost since the beginning of time. As the industrial revolution
took hold in Northern Europe, rickets became an epidemic. This devastating bone disease was
eventually eradicated as significant health problem because of the appreciation of the beneficial
effect of sunlight in producing vitamin D in the skin [6]. During the past two decades osteoporosis
has become a significant health issue affecting more than 20 million elderly Americans and costing
$6 billion dollars that by the year 2020 we will begin the colonization of the Moon and travel to
Mars. This exciting new era in space exploration could result in a new bone disease caused by
microgravity. If we are unable to prevent or reverse microgravity-induced bone loss, this negative
effect on the skeleton could severely limit human aspirations to explore and colonize the universe.
As we initiate a program for long-term human habitation in a mierogravity environment on board
Space Station Freedom and the Moon there remains concern about the acute and chronic loss of
bone mineral. Acutely the rapid loss of bone mineral in combination with microgravity-induced
hemodynamic changes could significantly increase the risk of kidney stones and soft tissue
calcification. Chronic unrelenting bone loss could compromise its structural integrity to such a
degree that when astronauts are exposed to the G-forces upon reentry into Earth's gravitational
field, micro- and macrofractures of the skeletal network could occur. In addition, since the entire
skeleton is unloaded in microgravity, it is possible that its three-dimensional structure is
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reorganized to such a degree that when astronauts return to Earth and initiate routine activity in a
one-g environment that micro- and macrofractures of the skeleton could occur as the body realigns
the framework of the skeleton to adapt to the forces put upon it by Earth's gravity.
The Effect of Bed Rest and Mlcrogravlty on Bone Metabolism
The model that is most often used to evaluate the potential impact of microgravity on bone and
calcium metabolism is to unload the skeleton of healthy subjects by putting them at strict bed rest
[4, 9, 14, 20]. Schneider and McDonald [14] and Arnaud, Schneider, and Morey-Holton [1]
measured intestinal calcium transport 4 weeks before and 20 weeks during strict bed rest. They
showed the efficiency of intestinal calcium absorption gradually declined during the first 4 weeks
of bed rest and plateaued to about 50 percent of the original level during that last 16 weeks (Figure
t).
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Figure 1. The intestinal absorption of calcium estimated from balance data in 19 to 47 healthy
subjects immobilized by bed rest for I6 weeks. Absorption was determined in
subjects consuming 1000 mg daily (reproduced with permission).
An increase in the mobilization of calcium from the skeleton may transiently increase the circulating
ionized calcium concentrations which in turn caused a decrease in parathyroid hormone (PTH)
secretion [1, 16]. A decrease in PTH secretion would result in the renal wasting of calcium
causing an increased urinary output of calcium (Figure 2). The decrease in intestinal calcium
absorption, that was most likely caused by a decrease in the PTH mediated metabolism of 25-
hydroxyvitamin D to 1,25-dihydroxyvitamin D, resulted in an increase loss of calcium in the feces
(Figure 2). This caused a negative calcium balance of approximately 200 mg/day during the last 16
weeks of bed rest (Figure 2).
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Figure 2. The excretion of calcium in the urine and feces, in milligrams per day, in 12 to 32
healthy subjects immobilized by bed rest for 20 weeks. Dietary calcium was kept
constant in these subjects at 1000 mg/d. Fecal calcium was corrected.for time by
polyethylene glycol 4000 administered three times daily in a dose 500 rag. The
lowest panel shows the results of the balance study estimated from the intake and
excretion of calcium in the urine and,feces (reproduced with permission).
Urinary hydroxyproline concentrations were increased providing evidence that the increase loss of
calcium in the urine was partly due to an increase turn-over of the bone (Figure 3).
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Figure 3. The daily urinary excretion of hydroxyproline and calcium in the urine. Excretion
is shown as the percentage of increase from the ambulatory control period of 4
weeks in 14 to 40 normal subjects during 20 weeks of bed rest (reproduced with
permission).
Bone density measurements of the calcaneous from the bed-rest subjects showed a marked decline
in bone mineral density. A significant decrease in the calcaneal bone density was evident by 5 to 8
weeks and continued to decline at about the same rate for the next 20 weeks. Approximately 30
percent of the bone mineral density was lost by the end of the study (Figure 4).
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Figure 4. Photon absorptionometry of the calcaneous. Percent decrease from ambulatory
values during untreated bed rest (reproduced with permission).
The results of these bed-rest studies have mirrored the observations seen in astronauts and
cosmonauts exposed to microgravity. Rambaut, Leach, and Whedon [11] observed significant
increases in urinary calcium excretion in Skylab 4 astronauts (Figure 5).
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Figure $. Urinary calcium in Skylab 4 astronauts (reproduced with permission).
They also found a significant decrease in calcaneous bone density during the 84-day mission on
board Skylab 4 (Figure 6).
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Figure 6. Calcaneal mineral loss as a function of Skylab flight duration (reproduced with
permission).
Parfitt [10] analyzed the calcaneal mineral bone density in astronauts on board Skylabs 2, 3 and 4
and found a significant decrease of about 4 percent in the longest flights of 59 and 84 days. By
contrast no significant changes were noted in the cortical bone density of the radius and ulna in the
same astronauts. The Skylab astronauts experienced a negative calcium balance of about 200 to
300 mg/day. Parfitt's analysis of the Skylab 4 astronauts' calcium metabolism data also revealed
that they lost about 300 mg of calcium a day that resulted in a total body loss of about 18 g (with a
range of 10 to 22 g). Most of the loss was not due to a decrease in intestinal absorption of calcium;
it was caused by an increase in urinary excretion of calcium. Parfitt concluded that two-thirds of
the total calcium loss came from trabecular bone and one third came from cortical bone. Similar
observations have been made in cosmonauts. In Table 1 all of the cosmonauts had significant
decrease in the bone density of after 140 days in microgravity [17].
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Table 1. Percentage change in mineral content of calcaneous in cosmonauts
Crew Flight Postflight Entire Monthly
Member Duration (days) Testing Day Hight Average
CDR 140 5 -3.0 -0.64
FLE 140 4 - 19.8 -4.24
CDR 175 5 -9.8 -1.69
FLE 175 5 -3.0 -0.51
CDR 184 14 -9.6 -1.56
FLE 184 14 -4.4 -0.71
CDR 75 4 -0.9 -0.36
FLE 75 4 -3.2 -1.31
Physiologic Function of the Skeleton
In light of the observations just presented there is the possibility that a significant amount of
skeletal mass will be lost during long-term space travel. One of the questions that is worthwhile
asking is, "Do we need a skeleton?" Is it possible that we will ultimately evolve in microgravity
into protoplastic-thinking beings that do not require a skeleton? Some of the functions of the
skeleton are obvious. It protects our soft vital organs, provides attachment for our musculature
and permits us to be mobile in our terrestrial environment. A more subtle but equally important
reason for the evolution of a calcified skeleton is to provide a storage depot for calcium. As
vertebrates evolved in the fertile oceans they were bathed in calcium. When they left this
environment for terra fi_a they were confronted with a calcium deprived environment. They
needed to deVelop mechanisms by which they could efficiently Utilize, assimilate, and store the
limited supplies of calcium that were in their environment. Vertebrates also developed elaborate
mechanisms to call upon these reserves at times of need.
Calcium plays an essential role in neurotransmission and neuromuscular function. In addition,
cytosolic calcium concentrations are carefully regulated and are responsible for a multitude of
cellular functions. Calcium also acts as an important second messenger to the cell. Therefore, I
believe that there is a need to maintain our skeletal structure if for no other reason than to act as a
storage site for calcium so that the body can call on this depot to maintain intra- and extracellular
calcium concentrations within physiologically acceptable limits.
Dynamics of Bone Formation and Bone Resorption: Strategies for Maintaining
Bone Mineral Density in a Microgravity Environment
When bone formation rates are greater than bone degradation rates there is an increase in bone
mass whereas, when bone formation rates are less than bone degradation rates there is a decrease
in bone mass. Osteoporosis is a state whereby the bone matrix along with the bone mineral is lost.
Osteomalacia on the other hand occurs when there is loss of bone mineral with the maintenance of
the matrix [8]. Although it is well documented that microgravity causes a decrease in bone mineral
content it is not known whether the bone mineral matrix is lost to the same degree causing
osteoporosis or whether the matrix is partially or fully maintained causing osteomalacia. If the
matrix is maintained in a microgravity environment then there is an opportunity to develop
therapeutic strategies to replenish the demineralized matrix. If, on the other hand, microgravity
induced bone demineralization causes the loss of the staging network (matrix) and calcium
D
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hydroxyapitite (mineral) that results in the destruction of the bone trabeculae, then it will be very
difficult if not impossible to restore the very fine trabecular network. Dempster et al. [3] have
demonstrated this in an exquisite fashion with scanning electromicroscopy. Figure 7a shows the
trabecular pattern from a healthy adult male skeleton while Figure 7b shows a marked loss in the
thickness and number of trabeculae as well as gaps between the trabeculae in a woman with
osteoporosis and multiple compression fractures of her spine. It would be very difficult to induce
bone cells to bridge these gaps.
Figure 7a. Low power scanning electron micrograph of an iliac crest biopsy from a 44-year-
old normal male (reproduced with permission).
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Figure 7b. Low power scanning electron micrograph of a iliac crest biopsy from a 47-year-old
osteoporotic female with multiple vertebral compression fractures (reproduced with
permission).
It is known from prolonged bed-rest studies that once the subjects are restored to their normal
activity they are capable of restoring their bone mineral density in the os calcis to prebed-rest levels
[4]. In Skylab studies follow-up bone density measurements at 3 months showed that the deficit
had been repaired in only one astronaut, 50 percent recovery in one, and no recovery in the third
who had measured calcaneal loss during space flight [13]. A 5-year follow-up of the mineral
content in the os calcis of nine crew members from the Skylab program when compared to eight of
their alternates who served as controls also showed a statistically significant loss compared to the
control group [18]. The authors cautioned, however, that there are so many potential causes for
the observed differences that more studies needed to be done. It is not known whether this
restoration would also occur in astronauts and cosmonauts who have experienced microgravity for
extended periods such as a 3-year mission to Mars. Furthermore, even if the bone mineral content
is restored we do not know whether the three dimensional structure of the bone could be restored
to its original condition.
Can Pharmacologic Intervention Regulate Bone Remodeling?
Can you maintain and/or restore bone mineral density while in microgravity? Schneider and
MacDonald [14] evaluated a variety of therapies including lower body negative pressure, exercise,
static compression, calcitonin, disphosphonate, phosphate, and calcium plus phosphate, and
concluded that they were unable to prevent negative calcium balan_ during bed rest (Figures 8 and
9).
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Figure 8. Mean calcium balance of the final week of study during untreated bed rest and in
eight physical interventions tried during bed rest (lower body negative pressure
[LBNP]) (reproduced with permission).
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Figure 9. Mean calcium balance during the final week of study during untreated bed rest and
in four biochemical therapies tried during bed rest (etidronate [EHDP]) (reproduced
with permission).
There is mounting evidence that both 1,25(OH)2D and parathyroid hormone not only enhance bone
calcium mobilization but also act as anabolic hormones to maintain bone remodeling activities.
Mature osteoclasts do not possess receptors for either 1,25(OH)2D or PTH. Instead it is now
believed that both of these hormones act on osteoblasts to induce cytokines that regulate
osteoclastic activity [6]. Additionally 1,25(OH)2D and PTH may mobilize stem cells to become
mature osteoclasts. Other factors that may play a role in the bone remodeling process include
TGF-beta and other bone growth factors. In some studies calcitonin has been shown to increase
bone mineral density, but in general it is believed to be an agent to inhibit the bone mobilization and
has little effect on the bone remodeling process. Of great interest is the possibility of activating
then depressing the bone remodeling activity. This has led to a new cyclic therapy called ADFR
(activation, depression, free period, repeat). Although preliminary results suggests that PTH
followed by 1,25(OH)2D3 or phosphate followed by 1,25(OH)2D3 may significantly increase
spinal bone density [15], Schneider and MacDonald [14] have reported that during bed rest
calcitonin, phosphate, or diphosphonate therapy did not significantly reverse the negative calcium
balance although some improvement was found in the group receiving high amounts of
diphosphonate. Recently Judge et al. [7] evaluated bone biopsies from four male volunteers after
17 weeks of bed rest and found a mismatch between bone resorption and bone formation, whereby
bone resorption continued or was increased while bone formation was decreased. Arnaud et al.
[2] evaluated bone biopsies from volunteers after a 2-week period of bed rest. After double
tetracycline labeling, it was found that bone formation rates significantly diminished in six
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subjects, was unchanged in one, and higher in one subject who was a swimmer (personal
communication).
Can Bone Cells Adapt to Microgravity?
Little is known about the impact of microgravity on bone cell activity. Can bone cells adapt to a
microgravity environment? Are bone cells addicted to gravity and therefore require gravity to
maintain normal bone remodeling activity? An insight into these questions has recently become
available as a result of a study on board STS-59. Sixteen fertilized chicken eggs at gestational ages
of 2 and 9 days were housed in a incubator and flown on board the Space Shuttle Discovery.
Control eggs of the same gestational ages were maintained in a similar incubator and exposed to the
vibrations and jostling to simulate liftoff and reentry. After the 5-day flight one-half of the eggs
from both groups were immediately sacrificed. The 2-day old embryos that were flight flown all
stopped developing and died within 24 hours, whereas all of the 2-day old control embryos
survived. The flight flown 9-day old embryos all developed similar to the control group. One-half
of the flight flown and control embryos had their bones evaluated. Preliminary results suggest that
the bone modeling process in the flight flown animals was no different from the earth controls
[19]. These results suggest that microgravity does not alter the bone mineralization process.
Therefore, it is likely that bone cells become adapted to gravity. Once exposed to microgravity
they decrease their activity. Thus, if we could understand what the signal or signals are that
microgravity provides to bone cells to limit their activity, it may be possible to reverse this action.
Alternatively it may be that if humans are born in a microgravity environment that their bone cells
would develop normally and a normal skeleton would evolve. As we contemplate exploring new
solar systems it may be that there will be a need for microgravity born astronauts to complete such
missions.
Conclusion
The likely physiologic events in calcium and bone metabolism that occur in a microgravity
environment are as follows:
. The unloading of the G-forces on the skeleton induce or inhibit a signal(s) that causes a
depression in bone formation and an acceleration in bone demineralization that results in an
increase in circulating ionized calcium concentrations.
2. The small rise in ionized calcium concentrations is recognized by the parathyroid glands,
which in turn decrease their secretion of parathyroid hormone.
3. The decrease in parathyroid secretion causes an increase renal loss of calcium into the
urine.
4. A decrease in PTH secretion also results in the depression of the metabolism of 25-
hydroxyvitamin D (25-OH-D) to 1,25-dihydroxyvitamin D (1,25[OH]2D) [5, 6].
The decrease in production of 1,25(OH)2D results in a decrease in the efficiency of intestinal
calcium transport (Figure 10). This cycle ultimately results in the continued wasting of the bone
mineral.
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Figure 10. Schematic representation of the hormonal control loop for vitamin D metabolism
and function. A reduction in the serum calcium below approximately 8.8 mg]mL
prompts a proportional increase in the secretion of parathyroid hormone, which
enhances the mobilization of calcium stores from bone. Parathyroid hormone also
promotes the synthesis of 1,25(OH)2D in the kidney, which in turn stimulates the
mobilization of calcium from bone and its absorption from the intestine (reproduced
with permission).
We do not know whether microgravity in enhancing the mobilization of calcium from bone also
causes the loss of bone matrix. If the matrix is maintained there is a good possibility that
astronauts can stimulate bone mineralization in a microgravity environment during prolonged space
travel. If, however, gravity adapted bone cells are further stimulated during astronaut training to
become more dependent on gravitational forces then the acute loss of Earth's G-force could
accelerate the mobilization of calcium from the bones of astronauts. A detraining period of the
skeleton may be an alternative approach to limiting the total amount of calcium lost from bone
during exposure to microgravity.
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